Showing results (11-20 of 4,996) with videos related to
Sort By:
Pageof 500
American Journal of Clinical Oncology|October 24, 2002
Expression of the murine double minute gene 2 oncoprotein in esophageal squamous cell carcinoma as a novel marker for lack of response to chemoradiotreatmentMasahide Ikeguchi, Tsuyoshi Ueda, Kenji Fukuda, et al.American Journal of Clinical Oncology|October 24, 2002
Adjuvant epirubicin with or without Ifosfamide for adult soft-tissue sarcomaRoberto Petrioli, Andrea Coratti, Pierpaolo Correale, et al.American Journal of Clinical Oncology|October 24, 2002
Results of recent therapy for non-small-cell lung cancer with brain metastasis as the initial relapseYasuhiko Ohta, Makoto Oda, Yoshio Tsunezuka, et al.American Journal of Clinical Oncology|October 24, 2002
Dose-intense ifosfamide/doxorubicin/cisplatin based chemotherapy for osteosarcoma in adultsShailesh J Patel, James W Lynch, Thomas Johnson, et al.American Journal of Clinical Oncology|October 24, 2002
Phase II study of docetaxel and gemcitabine combination chemotherapy in non-small-cell lung cancer patients failing previous chemotherapyYuh-Min Chen, Reury-Perng Perng, Wei-Chun Lin, et al.American Journal of Clinical Oncology|February 22, 2000
Poorly differentiated carcinoma of the lung presenting with Lambert--Eaton myasthenic syndromeS G Nair, B S Kumar, B RajanAmerican Journal of Clinical Oncology|February 22, 2000
Oral etoposide for Merkel cell carcinoma in patients previously treated with intravenous etoposideE Fenig, B Brenner, E Njuguna, et al.American Journal of Clinical Oncology|February 22, 2000
Thrombotic thrombocytopenic purpura in metastatic carcinoma of the breastN von Bubnoff, M Sandherr, F Schneller, et al.American Journal of Clinical Oncology|October 16, 1999
'Neo-FAC' (5-fluorouracil, doxorubicin, and cyclophosphamide) for poor-prognosis stage IV breast cancer: a Southwest Oncology Group Phase II StudyG K Ellis, S Green, R B Livingston, et al.American Journal of Clinical Oncology|October 16, 1999
Clinical factors and prognosis in non-small cell lung cancerS J Martins, J R PereiraPageof 500